| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $12.73M | - | |
| VP | 63.6K | $2.20M | - | |
| Other | 52.8K | $1.83M | - | |
| Other | 52.7K | $1.83M | - | |
| VP | 13.0K | $451.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Nazzi Gianfranco | EVP, International Markets | Sale+OE | 21,635 | $12.72 | $275,216.67 | -13.5% | |
| Feb 9, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 29,496 | $12.69 | $374,436.97 | -11.6% | |
| Feb 9, 2021 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 17,979 | $12.72 | $228,709.06 | -16.7% | |
| Feb 9, 2021 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 29,657 | $12.69 | $376,480.79 | -17.2% | |
| Feb 9, 2021 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 68,422 | $12.72 | $870,389.42 | -47.1% | |
| Sep 9, 2020 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 333 | $8.98 | $2,991.81 | -3.0% | |
| Aug 11, 2020 | Crane Rosemary A | Director | Sale+OE | 2,860 | $11.90 | $34,037.72 | -7.9% | |
| Mar 17, 2020 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,359 | $7.16 | $16,898.70 | -44.2% | |
| Mar 17, 2020 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 470 | $7.16 | $3,366.85 | -3.1% | |
| Mar 17, 2020 | Nazzi Gianfranco | EVP, International Markets | Sale+OE | 345 | $7.17 | $2,474.13 | -1.7% |